glp-1 weight management wichita Home GLP-1 drugs are expanding beyond

Global prevalence and trends of overweight and obesity among preschool children

A 48-week Phase 2 trial reported in The Lancet in 2025 showed mean weight reduction ranging from approximately 9% at the lowest dose to 20% at the highest dose, compared with 0.4% on placebo

IQVIA prescription data put ongoing users at approximately 1.5 million in March 2025 alone, rising to over 2 million paying privately by July 2025

Cheapest Places to Get Semaglutide (GLP-1) Online In 2026 Editorial Disclosure: Our clinical reviews are independent and science-led

The trouble with drive-thru drugs The demand for medication at these businesses is clear